New Treatments, Universal Screening May Ease Burden of Perinatal Depression
The most common, most underdiagnosed, and most undertreated pregnancy-related complication in the United States is perinatal depression — depression that occurs during pregnancy or within the first year after delivery. An estimated 10 to 20 percent of new mothers experience perinatal depression (a more inclusive term than postpartum depression), with half of these women going undiagnosed and untreated.
SWHR Engages With FDA on Patient-Focused Drug Development
SWHR seeks to ensure that meaningful input from women is included in the development and regulatory review of new medical products.
SWHR Hires Sherie Lou Santos as Director of Science Policy
The Society for Women’s Health Research has hired Sherie Lou Z. Santos, MPH, as director of science policy. In this role, Santos will envision, direct, and implement creative science programs...
Roche Diagnostics CMO Alan Wright Joins SWHR Board of Directors
The Society for Women’s Health Research (SWHR) is pleased to announced the election of Alan Wright, MD, MPH, chief medical officer at Roche Diagnostics Corp., to its Board of Directors.
SWHR Praises Work of Dedicated FDA Women’s Health Advocate Marsha Henderson
In her 22 years at the Food and Drug Administration, Marsha B. Henderson has had a profound influence on the advancement of women’s health research. When she retires at the end of this year, the FDA will surely feel the absence of this dedicated advocate and her leadership as FDA’s associate commissioner for women’s health and director of the Office of Women’s Health (OWH).